Literature DB >> 11684832

Expression of PDGF-A, TGFb and VCAM-1 during the developmental stages of experimental atherosclerosis.

E P Misiakos1, G Kouraklis, E Agapitos, D Perrea, G Karatzas, H Boudoulas, P E Karayannakos.   

Abstract

PURPOSE: A considerable number of growth factors, cytokines, and adhesion molecules are implicated in the development of atherosclerotic lesions. These molecules interact in a complex network influencing the evolution of several processes, such as lipid metabolism, cellular proliferation and tissue repair. The aim of this study was to evaluate the expression of the growth factors PDGF-A, and TGFb, and the adhesion molecule VCAM-1 in the sequential steps of experimental atherogenesis.
METHODS: Forty-two New Zealand white male rabbits were divided into 4 groups. The group A rabbits (n = 8) received normal diet and served as control animals. The remaining groups were fed with a diet enriched with 1% cholesterol and 6% corn oil. The rabbits of group B (n = 9) were sacrificed 1 month after the beginning of the study, of group C (n = 15) after 2 months and of group D (n = 10) after 3 months. In tissue sections of the aortic arch the antibodies of the prementioned factors were detected immunohistochemically.
RESULTS: In group A only TGFb and PDGF-A were detectable. In lesions of the first month PDGF-A expression was high but declined towards the third month. VCAM-1 expression was getting more intense up to the second month and subsided thereafter. TGFb expression intensified towards the third month. Changes in the expression of these factors were statistically significant.
CONCLUSION: PDGF-A, responsible for the uncontrollable growth of smooth muscle cells, and VCAM-1, regulating monocyte recruitment in the intima, acts mainly during the early stages of atherogenesis. TGFb, one of the main factors controlling the formation of connective tissue matrix, has a gradually increasing expression towards the third month contributing probably to the fibrous plaque formation. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684832     DOI: 10.1159/000049716

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

Review 1.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

2.  Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes.

Authors:  Hyunggun Kim; Patrick H Kee; Yonghoon Rim; Melanie R Moody; Melvin E Klegerman; Deborah Vela; Shao-Ling Huang; David D McPherson; Susan T Laing
Journal:  Ultrasound Med Biol       Date:  2015-03-24       Impact factor: 2.998

3.  Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes.

Authors:  Patrick H Kee; Hyunggun Kim; Shaoling Huang; Susan T Laing; Melanie R Moody; Deborah Vela; Melvin E Klegerman; David D McPherson
Journal:  Ultrasound Med Biol       Date:  2014-03-05       Impact factor: 2.998

4.  The amiloride derivative phenamil attenuates pulmonary vascular remodeling by activating NFAT and the bone morphogenetic protein signaling pathway.

Authors:  Mun Chun Chan; Alexandra S Weisman; Hara Kang; Peter H Nguyen; Tyler Hickman; Samantha V Mecker; Nicholas S Hill; Giorgio Lagna; Akiko Hata
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

5.  Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression.

Authors:  Mun Chun Chan; Aaron C Hilyard; Connie Wu; Brandi N Davis; Nicholas S Hill; Ashish Lal; Judy Lieberman; Giorgio Lagna; Akiko Hata
Journal:  EMBO J       Date:  2009-12-17       Impact factor: 11.598

6.  Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors.

Authors:  Giorgio Lagna; Manching M Ku; Peter H Nguyen; Nicole A Neuman; Brandi N Davis; Akiko Hata
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

7.  Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis.

Authors:  C Severi; R Sferra; A Scirocco; A Vetuschi; N Pallotta; A Pronio; R Caronna; G Di Rocco; E Gaudio; E Corazziari; P Onori
Journal:  Eur J Histochem       Date:  2014-12-17       Impact factor: 3.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.